✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Biogen Inc

Common Name
Biogen
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
7,605
Ticker
BIIB
Exchange
NASDAQ/NGS
Description
Biogen Inc. is a globally recognized biotechnology company committed to discovering, developing, and delivering innovative therapies for neurological diseases. With a focus on serious medical conditio...

Biogen's Financial Statements Preview

Below are the financial statements of Biogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
Product revenue, net
7,213.5a
7,246.7a
7,987.8a
Revenue from anti-CD20 therapeutic programs
1,749.9a
1,689.6a
1,700.5a
Alzheimer's collaboration revenue
59.9a
0a
0a
Contract manufacturing, royalty and other revenue
652.6a
899.3a
485.1a
Total revenue
9,675.9a
9,835.6a
10,173.4a
Cost and expense
Cost of sales, excluding amortization and impairment of acquired intangible assets
-2,310.4a
-2,533.4a
-2,278.3a
Research and development
-2,041.8a
-2,462a
-2,231.1a
Selling, general and administrative
-2,403.7a
-2,549.7a
-2,403.6a
Amortization and impairment of acquired intangible assets
-446.7a
-240.6a
-365.9a
Collaboration profit sharing/(loss reimbursement)
254.4a
218.8a
-7.4a
(Gain) loss on fair value remeasurement of contingent consideration
27.7a
0a
-209.1a
Restructuring charges
-30.2a
-218.8a
-131.1a
Gain on sale of priority review voucher, net
-88.6a
0a
0a
Gain on sale of building, net
0a
0a
-503.7a
Other (income) expense, net
343.6a
315.5a
-108.2a
Total cost and expense
-7,769.9a
-8,538.8a
-6,581.6a
Income before income tax (benefit) expense and equity in (income) loss of investee, net of tax
1,906a
1,296.8a
3,591.8a
Income tax (benefit) expense
-273.8a
-135.3a
-632.8a
Equity in (income) loss of investee, net of tax
0a
0a
-2.6a
Net income
1,632.2a
1,161.5a
2,961.6a
Net income (loss) attributable to noncontrolling interests, net of tax
0a
0.4a
-85.3a
Net income attributable to Biogen Inc.
1,632.2a
1,161.1a
3,046.9a
Limited Data Preview
You are viewing a limited preview of Biogen’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Biogen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biogen’s data sources below and access millions more through our Disclosure Search.

a. Biogen's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?